Urine test for early bladder cancer detection
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is testing a new, non-invasive urine test that looks for specific DNA changes (methylation patterns) to find bladder cancer early. If you have bladder cancer or are a healthy person willing to help, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with bladder cancer (either early-stage or muscle-invasive) OR you are a healthy volunteer without a history of bladder cancer.
- You are able to follow the study procedures (like giving urine samples and signing consent forms).
- If you have bladder cancer, it must not have spread to other organs (metastatic).
- If you are a healthy volunteer, you cannot have had bladder cancer in the past or be suspected of having any cancer, and you cannot be on treatments that could affect urine test results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a urine DNA test may help find bladder cancer (or clues that it might be present), especially in people with symptoms or higher risk. You may be asked to provide urine and also complete standard tests like imaging, a cystoscopy, or pathology checks.
This study looks for specific DNA changes in bladder cancer tumors using a precise test. It aims to better understand the disease and may help guide future treatment choices.
This study tests a new urine test that looks for DNA changes to find bladder or urinary tract cancer in people who have blood in their urine. The goal is to see if this simple test can detect cancer early.
This study examines whether a simple blood test can detect cancer DNA (circulating tumor DNA, or ctDNA) in patients with a specific type of bladder cancer. Detecting this DNA in blood may help doctors predict how the cancer will behave and guide future treatment decisions.
This trial tests a urine test that looks for tumor DNA to help doctors decide when you need a cystoscopy (a scope in the bladder). It is for people with high-risk or very high-risk non-muscle-invasive bladder cancer who have already had surgery to remove all visible tumors.
This trial is testing if a simple urine test can help track prostate or bladder cancer over time without needing invasive procedures. It includes five specific patient groups with different stages of these cancers.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.